ライフサイエンスコーパス: poly ADP ribose polymerase inhibitor

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 y, or had received previous treatment with a poly(ADP-ribose) polymerase inhibitor.

2 reaks (DSBs), and increased sensitivity to a poly(ADP-ribose) polymerase inhibitor.

3 eficient cells were sensitive to olaparib, a poly(ADP-ribose) polymerase inhibitor.

4 Ialpha inhibitor, L67, in combination with a poly (ADP-ribose) polymerase inhibitor.

5 ation) activity and is affected by canonical poly(ADP-ribose) polymerase inhibitors.

6 h in neurons, all of which were prevented by poly(ADP-ribose) polymerase inhibitors.

7 vic radiotherapy, or previous treatment with poly (ADP-ribose) polymerase inhibitors.

8 ndicated by the cytoprotective effect of the poly(ADP-ribose) polymerase inhibitor 3-aminobenzamide.

9 The poly(ADP-ribose) polymerase inhibitor, 3-aminobenzamide

10 2 deficient and sensitive to cisplatin and a poly(ADP-ribose) polymerase inhibitor, AG14361, whereas

11 Olaparib is a poly(ADP-ribose) polymerase inhibitor and cediranib is a

12 Poly ADP-ribose polymerase inhibitors are a promising ne

13 mor-derived DNA were resistant to platin- or poly ADP ribose polymerase inhibitor-based chemotherapy.

14 only when cultured in medium containing the poly(ADP-ribose) polymerase inhibitor benzamide.

15 In response to DNA damage induced by poly(ADP-ribose) polymerase inhibitors, CHD4 deficiency

16 lethality anticancer therapeutics, including poly ADP-ribose polymerase inhibitors for BRCA1- and BRC

17 The development of poly-(ADP)ribose polymerase inhibitors for BRCA1-mutatio

18 Maintenance therapy with olaparib, a poly ADP ribose polymerase inhibitor given post-platinum

19 Use of poly (ADP-ribose)-polymerase inhibitors has shown that t

20 Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer ac

21 Veliparib, an oral poly(ADP-ribose) polymerase inhibitor, has been shown to

22 Promising novel therapeutic agents such as poly (ADP-ribose) polymerase inhibitors have increased a

23 Although poly(ADP-ribose) polymerase inhibitors have shown promis

24 IEL3 provides further evidence that use of a poly(ADP-ribose) polymerase inhibitor in the maintenance

25 gagement of the chemotherapeutic Olaparib, a poly(ADP-ribose) polymerase inhibitor, in live cells and

26 ion with doxorubicin, bortezomib, as well as poly(ADP-ribose) polymerase inhibitor NU1025 and Fas-act

27 d treatments such as antiangiogenic drugs or poly (ADP-ribose) polymerase inhibitors offer potential

28 We investigated in vitro sensitivity to the poly (ADP-ribose) polymerase inhibitor olaparib (AZD2281

29 rpose Durable and long-term responses to the poly (ADP-ribose) polymerase inhibitor olaparib are obse

30 The poly(ADP-ribose) polymerase inhibitor olaparib has shown

31 tions initially respond well to platinum and poly(ADP-ribose) polymerase inhibitor (PARPi) therapy; h

32 uely responsible for cellular sensitivity to poly(ADP-ribose) polymerase inhibitors (PARPi) in BRCA1-

33 Poly (ADP-ribose) polymerase inhibitors (PARPis) are cli

34 Combination studies of PCI-24781 with the poly(ADP-ribose) polymerase inhibitor PJ34, an agent tho

35 rate alpha-ketoglutarate or treatment with a poly(ADP ribose) polymerase inhibitor protects reductive

36 Olaparib (AZD2281), an orally active poly (ADP-ribose) polymerase inhibitor that induces synt

37 at CHD4-depleted cells are more sensitive to poly(ADP-ribose) polymerase inhibitor treatment.

38 Our data, together with the advent of poly(ADP-ribose) polymerase inhibitor trials, supports t

39 cells with mutant p53 were resistant to the poly(ADP-ribose) polymerase inhibitor, veliparib (2-[(2R

40 Poly ADP-ribose polymerase inhibitors were developed wit

41 Poly ADP-ribose polymerase inhibitors were predicted to

42 receptor tyrosine kinase inhibitor XL184 and poly (ADP-ribose) polymerase inhibitors which are in ear

43 Olaparib is an oral poly (ADP-ribose) polymerase inhibitor with activity in

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。